THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES

Header Logo

Connection

Michael Megaly to Treatment Outcome

Back to Details
This is a "connection" page, showing publications Michael Megaly has written about Treatment Outcome.
Michael Megaly
Connection Strength
7.388
Treatment Outcome
  1. Early vs. delayed mechanical circulatory support in patients with acute myocardial infarction and cardiogenic shock. Eur Heart J Acute Cardiovasc Care. 2024 May 28; 13(5):390-397.
    View in: PubMed
    Score: 0.147
  2. The summer effect on STEMI outcomes: Insights from teaching hospitals. Cardiovasc Revasc Med. 2024 Jan; 58:101-103.
    View in: PubMed
    Score: 0.140
  3. Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention of the Left Anterior Descending Artery. Am J Cardiol. 2023 04 15; 193:75-82.
    View in: PubMed
    Score: 0.135
  4. Utilization of TandemHeart in cardiogenic shock: Insights from the THEME registry. Catheter Cardiovasc Interv. 2023 03; 101(4):756-763.
    View in: PubMed
    Score: 0.135
  5. Meta-Analysis on Invasive Versus Conservative Strategy in Patients Older Than Seventy Years With Non-ST Elevation Myocardial Infarction. Am J Cardiol. 2023 01 01; 186:66-70.
    View in: PubMed
    Score: 0.132
  6. Utilization of Non-Drug-Eluting Devices for Inpatient Percutaneous Coronary Intervention in the United States. Am J Cardiol. 2023 01 01; 186:209-215.
    View in: PubMed
    Score: 0.132
  7. Extraplaque versus intraplaque tracking in chronic total occlusion percutaneous coronary intervention. Catheter Cardiovasc Interv. 2022 11; 100(6):1021-1029.
    View in: PubMed
    Score: 0.131
  8. Comparative Analysis of Patient Characteristics in Chronic Total Occlusion Revascularization Studies: Trials vs Real-World Registries. JACC Cardiovasc Interv. 2022 07 25; 15(14):1441-1449.
    View in: PubMed
    Score: 0.130
  9. Trends and Outcomes of Myocardial Infarction in Patients With Previous Coronary Artery Bypass Surgery. Am J Cardiol. 2022 09 15; 179:11-17.
    View in: PubMed
    Score: 0.129
  10. The MANTA Vascular Closure Device: Requiring Attention From Beginning to End, Reply. Cardiovasc Revasc Med. 2022 07; 40:207.
    View in: PubMed
    Score: 0.127
  11. Extra-Stent Subintimal Plaque Modification: A Novel Technique to Overcome Resistant Stent Underexpansion. Cardiovasc Revasc Med. 2022 07; 40S:276-278.
    View in: PubMed
    Score: 0.127
  12. Comparative Analysis of Patient Characteristics in Cardiogenic Shock Studies: Differences Between Trials and Registries. JACC Cardiovasc Interv. 2022 02 14; 15(3):297-304.
    View in: PubMed
    Score: 0.126
  13. Side Power Knuckle and Antegrade-Antegrade Dissection Re-Entry: Techniques to Overcome Difficulties in Chronic Occlusion?Revascularization. JACC Cardiovasc Interv. 2022 01 10; 15(1):e13-e15.
    View in: PubMed
    Score: 0.125
  14. Wire Entrapment and Unraveling in the Aorta: Snaring Technique for the Nonvisible Filament. JACC Cardiovasc Interv. 2022 01 24; 15(2):e21-e22.
    View in: PubMed
    Score: 0.125
  15. "Power Carlino": A Novel Method for Modifying Wire-Impenetrable Proximal Caps During Chronic Total Occlusion Revascularization. JACC Cardiovasc Interv. 2021 11 22; 14(22):2521-2522.
    View in: PubMed
    Score: 0.123
  16. Outcomes of successful vs. failed contemporary chronic total occlusion percutaneous coronary intervention. Cardiovasc Interv Ther. 2022 Jul; 37(3):483-489.
    View in: PubMed
    Score: 0.123
  17. Diabetic Patients Who Present With ST-Elevation Myocardial Infarction. Cardiovasc Revasc Med. 2022 05; 38:89-93.
    View in: PubMed
    Score: 0.121
  18. Trends and Outcomes of Uilization of Thrombectomy During Primary Percutaneous Coronary Intervention. Cardiovasc Revasc Med. 2022 03; 36:83-88.
    View in: PubMed
    Score: 0.120
  19. Complications and Failure Modes of Polymer-Jacketed Guidewires; Insights From the MAUDE Database. Cardiovasc Revasc Med. 2022 03; 36:132-135.
    View in: PubMed
    Score: 0.119
  20. Complications and failure modes of coronary embolic protection devices: Insights from the MAUDE database. Catheter Cardiovasc Interv. 2022 02; 99(2):405-410.
    View in: PubMed
    Score: 0.119
  21. Complications and Failure Modes of Covered Coronary Stents: Insights From the MAUDE Database. Cardiovasc Revasc Med. 2022 02; 35:157-160.
    View in: PubMed
    Score: 0.118
  22. Outcomes With Drug-Coated Balloons vs. Drug-Eluting Stents in Small-Vessel Coronary Artery Disease. Cardiovasc Revasc Med. 2022 02; 35:76-82.
    View in: PubMed
    Score: 0.118
  23. Complications and Failure Modes of Stingray LP Balloon: Insights From the MAUDE Database. Cardiovasc Revasc Med. 2022 02; 35:187-188.
    View in: PubMed
    Score: 0.118
  24. Complications of the MANTA Closure Device: Insights From MAUDE Database. Cardiovasc Revasc Med. 2022 01; 34:75-79.
    View in: PubMed
    Score: 0.117
  25. Outcomes of Percutaneous and Surgical Pulmonary Valve Implantation. Cardiovasc Revasc Med. 2021 11; 32:27-32.
    View in: PubMed
    Score: 0.116
  26. Reply: TAVR With or Without Embolic Cerebral Protection. JACC Cardiovasc Interv. 2020 12 14; 13(23):2817.
    View in: PubMed
    Score: 0.116
  27. Subintimal Plaque Modification and Subintimal Dissection and Reentry: Strategies to Turn Failure into Success. Interv Cardiol Clin. 2021 01; 10(1):65-73.
    View in: PubMed
    Score: 0.115
  28. Systematic review and meta-analysis of short-term outcomes with drug-coated balloons vs. stenting in acute myocardial infarction. Cardiovasc Interv Ther. 2021 Oct; 36(4):481-489.
    View in: PubMed
    Score: 0.114
  29. Ischemic Stroke With Cerebral Protection System During Transcatheter Aortic Valve Replacement. JACC Cardiovasc Interv. 2020 09 28; 13(18):2149-2155.
    View in: PubMed
    Score: 0.114
  30. Use of Intravascular Imaging in Patients With ST-Segment Elevation Acute Myocardial Infarction. Cardiovasc Revasc Med. 2021 09; 30:59-64.
    View in: PubMed
    Score: 0.114
  31. Risk Factors for the Development of Carotid Artery In-Stent Restenosis: Multivariable Analysis. Cardiovasc Revasc Med. 2021 03; 24:65-69.
    View in: PubMed
    Score: 0.114
  32. Coronary Intravascular Brachytherapy for Recurrent Coronary Drug-Eluting Stent In-Stent Restenosis: A Systematic Review and Meta-Analysis. Cardiovasc Revasc Med. 2021 02; 23:28-35.
    View in: PubMed
    Score: 0.113
  33. Outcomes With Combined Laser Atherectomy and Intravascular Brachytherapy in Recurrent Drug-Eluting Stent In-Stent Restenosis. Cardiovasc Revasc Med. 2021 01; 22:29-33.
    View in: PubMed
    Score: 0.112
  34. Retrograde Approach to Chronic Total Occlusion Percutaneous Coronary Intervention. Circ Cardiovasc Interv. 2020 05; 13(5):e008900.
    View in: PubMed
    Score: 0.111
  35. Telesupported procedures: when and how. Catheter Cardiovasc Interv. 2020 04 01; 95(5):911-913.
    View in: PubMed
    Score: 0.110
  36. Outcomes of Chronic Total?Occlusion Percutaneous Coronary Intervention in Patients With Prior Bypass Surgery. JACC Cardiovasc Interv. 2020 04 13; 13(7):900-902.
    View in: PubMed
    Score: 0.110
  37. Short- and Long-Term Outcomes in Patients With New-Onset Persistent Left Bundle Branch Block After Transcatheter Aortic Valve Replacement. Cardiovasc Revasc Med. 2020 10; 21(10):1299-1304.
    View in: PubMed
    Score: 0.110
  38. Primary Orbital Atherectomy for Treating a Heavily Calcified Balloon-Uncrossable Lesion. Cardiovasc Revasc Med. 2020 11; 21(11S):96-99.
    View in: PubMed
    Score: 0.109
  39. Outcomes of intravascular brachytherapy for recurrent drug-eluting in-stent restenosis. Catheter Cardiovasc Interv. 2021 01 01; 97(1):32-38.
    View in: PubMed
    Score: 0.109
  40. Outcomes after pacemaker implantation in patients with new-onset left bundle-branch block after transcatheter aortic valve replacement. Am Heart J. 2019 12; 218:128-132.
    View in: PubMed
    Score: 0.108
  41. Outcomes with retrograde versus antegrade chronic total occlusion revascularization. Catheter Cardiovasc Interv. 2020 11; 96(5):1037-1043.
    View in: PubMed
    Score: 0.108
  42. Outcomes With Deferred Versus Performed Revascularization of Coronary Lesions With Gray-Zone Fractional Flow Reserve Values. Circ Cardiovasc Interv. 2019 12; 12(12):e008315.
    View in: PubMed
    Score: 0.108
  43. Radial Versus Femoral Access in Chronic Total Occlusion Percutaneous Coronary Intervention. Circ Cardiovasc Interv. 2019 06; 12(6):e007778.
    View in: PubMed
    Score: 0.104
  44. Outcomes with cilostazol after endovascular therapy of peripheral artery disease. Vasc Med. 2019 08; 24(4):313-323.
    View in: PubMed
    Score: 0.103
  45. Outcomes with Drug-Coated Balloons in Percutaneous Coronary Intervention in Diabetic Patients. Cardiovasc Revasc Med. 2020 01; 21(1):78-85.
    View in: PubMed
    Score: 0.103
  46. Outcomes with drug-coated balloons in small-vessel coronary artery disease. Catheter Cardiovasc Interv. 2019 04 01; 93(5):E277-E286.
    View in: PubMed
    Score: 0.101
  47. Outcomes With Drug-Coated Balloons for Treating the Side Branch of Coronary Bifurcation Lesions. J Invasive Cardiol. 2018 11; 30(11):393-399.
    View in: PubMed
    Score: 0.099
  48. Meta-analysis of the impact of successful chronic total occlusion percutaneous coronary intervention on left ventricular systolic function and reverse remodeling. J Interv Cardiol. 2018 Oct; 31(5):562-571.
    View in: PubMed
    Score: 0.098
  49. Clinical Outcomes of Patients Experiencing Transient Loss of Pulse Pressure During High-Risk PCI with Impella. J Card Fail. 2024 Oct; 30(10):1287-1299.
    View in: PubMed
    Score: 0.038
  50. Impact of transcatheter edge to edge repair in functional mitral regurgitation and cardiac resynchronization-therapy nonresponders. Catheter Cardiovasc Interv. 2024 Oct; 104(4):829-836.
    View in: PubMed
    Score: 0.037
  51. Outcomes With Malignancy-Associated High-Risk Pulmonary Embolism: A Nationwide Analysis. Mayo Clin Proc. 2024 Jan; 99(1):81-89.
    View in: PubMed
    Score: 0.035
  52. Outcomes of Chronic Total Occlusion Percutaneous Coronary Interventions in Patients With Previous Coronary Artery Bypass Graft Surgery. Am J Cardiol. 2023 10 15; 205:40-49.
    View in: PubMed
    Score: 0.035
  53. Outcomes and Institutional Variation in Arterial Access Among Patients With AMI and Cardiogenic Shock Undergoing PCI. JACC Cardiovasc Interv. 2023 06 26; 16(12):1517-1528.
    View in: PubMed
    Score: 0.035
  54. Extra-plaque rotational atherectomy for treating a balloon uncrossable ostial right coronary artery chronic total occlusion. Cardiovasc Revasc Med. 2024 Jan; 58:50-51.
    View in: PubMed
    Score: 0.034
  55. The impact of moderate aortic stenosis in acute myocardial infarction: A multicenter retrospective study. Catheter Cardiovasc Interv. 2023 07; 102(1):159-165.
    View in: PubMed
    Score: 0.034
  56. Outcomes with catheter-directed thrombolysis vs. catheter-directed embolectomy among patients with high-risk pulmonary embolism: a nationwide analysis. Eur Heart J Acute Cardiovasc Care. 2023 Apr 17; 12(4):224-231.
    View in: PubMed
    Score: 0.034
  57. Intravascular Imaging Use in Percutaneous Coronary Interventions of Chronic Total Occlusions. J Invasive Cardiol. 2023 05; 35(5):E265-E268.
    View in: PubMed
    Score: 0.034
  58. Meta-Analysis on Transcarotid Versus Transfemoral and Other Alternate Accesses for Transcatheter Aortic Valve Implantation. Am J Cardiol. 2023 04 01; 192:196-205.
    View in: PubMed
    Score: 0.034
  59. Outcomes with plug-based versus suture-based vascular closure device after transfemoral transcatheter aortic valve replacement: A systematic review and meta-analysis. Catheter Cardiovasc Interv. 2023 03; 101(4):817-827.
    View in: PubMed
    Score: 0.034
  60. Impact of proximal cap ambiguity on the procedural techniques and outcomes of chronic total occlusion percutaneous coronary intervention: Insights from the PROGRESS-CTO Registry. Catheter Cardiovasc Interv. 2023 03; 101(4):737-746.
    View in: PubMed
    Score: 0.034
  61. External validation of the PROGRESS-CTO complication risk scores: Individual patient data pooled analysis of 3 registries. Int J Cardiol. 2023 03 15; 375:14-20.
    View in: PubMed
    Score: 0.033
  62. Use of Mechanical Circulatory Support in Chronic Total Occlusion Percutaneous Coronary Intervention. Am J Cardiol. 2023 02 15; 189:76-85.
    View in: PubMed
    Score: 0.033
  63. Gender differences in chronic total occlusion percutaneous coronary interventions: Insights from the PROGRESS-CTO registry. Catheter Cardiovasc Interv. 2022 11; 100(6):1010-1018.
    View in: PubMed
    Score: 0.033
  64. A Systematic Review and Meta-Analysis of Clinical Outcomes of Patients Undergoing Chronic Total Occlusion Percutaneous Coronary Intervention. J Invasive Cardiol. 2022 11; 34(11):E763-E775.
    View in: PubMed
    Score: 0.033
  65. Sex Differences in Management and Outcomes Among Patients With High-Risk Pulmonary Embolism: A Nationwide Analysis. Mayo Clin Proc. 2022 10; 97(10):1872-1882.
    View in: PubMed
    Score: 0.033
  66. Intravascular lithotripsy in chronic total occlusion percutaneous coronary intervention: Insights from the PROGRESS-CTO registry. Catheter Cardiovasc Interv. 2022 10; 100(4):512-519.
    View in: PubMed
    Score: 0.032
  67. Transcatheter edge-to-edge repair of the tricuspid valve: The US?experience. Catheter Cardiovasc Interv. 2022 05; 99(6):1859-1866.
    View in: PubMed
    Score: 0.032
  68. Temporal Trends in Retrograde Crossing of Epicardial Collaterals in Chronic Total Occlusion Percutaneous Coronary Intervention. J Invasive Cardiol. 2022 04; 34(4):E294-E295.
    View in: PubMed
    Score: 0.032
  69. In-hospital outcomes of transesophageal versus intracardiac echocardiography guided left atrial appendage closure. Catheter Cardiovasc Interv. 2022 04; 99(5):1572-1581.
    View in: PubMed
    Score: 0.031
  70. Update on chronic total occlusion percutaneous coronary intervention. Prog Cardiovasc Dis. 2021 Nov-Dec; 69:27-34.
    View in: PubMed
    Score: 0.031
  71. Complications of Penumbra Indigo Aspiration Device in Pulmonary Embolism: Insights From MAUDE Database. Cardiovasc Revasc Med. 2022 06; 39:97-100.
    View in: PubMed
    Score: 0.031
  72. Sex Differences in Trends and In-Hospital Outcomes Among Patients With Critical Limb Ischemia: A Nationwide Analysis. J Am Heart Assoc. 2021 09 21; 10(18):e022043.
    View in: PubMed
    Score: 0.031
  73. Impact of Hospital Procedural Volume on?Outcomes After Endovascular Revascularization for Critical Limb?Ischemia. JACC Cardiovasc Interv. 2021 09 13; 14(17):1926-1936.
    View in: PubMed
    Score: 0.031
  74. Computed tomography angiography co-registration with real-time fluoroscopy in percutaneous coronary intervention for chronic total occlusions. EuroIntervention. 2021 Aug 06; 17(5):e433-e435.
    View in: PubMed
    Score: 0.030
  75. Complications and Failure Modes of the Penumbra Indigo CAT RX Aspiration System in Percutaneous Coronary Intervention: Insights From the MAUDE Database. Cardiovasc Revasc Med. 2022 04; 37:147-148.
    View in: PubMed
    Score: 0.030
  76. Meta-analysis comparing valve-in-valve TAVR and redo-SAVR in patients with degenerated bioprosthetic aortic valve. Catheter Cardiovasc Interv. 2021 11 01; 98(5):940-947.
    View in: PubMed
    Score: 0.030
  77. The transseptal puncture experience: Safety insights from FDA MAUDE database. Catheter Cardiovasc Interv. 2021 11 15; 98(6):E855-E861.
    View in: PubMed
    Score: 0.030
  78. Coronary artery bypass grafting after acute ST-elevation myocardial infarction. J Thorac Cardiovasc Surg. 2023 02; 165(2):672-683.e10.
    View in: PubMed
    Score: 0.030
  79. Benefit of Transcatheter Aortic Valve Replacement in Patients With Paradoxical Low-Flow Low-Gradient Versus High-Gradient Aortic Stenosis and Preserved Left Ventricular Function. Circ Cardiovasc Interv. 2021 03; 14(3):e010042.
    View in: PubMed
    Score: 0.029
  80. Contemporary Revascularization Strategies and Outcomes Among Patients With Diabetes With Critical Limb Ischemia: Insights From the National Inpatient Sample. JACC Cardiovasc Interv. 2021 03 22; 14(6):664-674.
    View in: PubMed
    Score: 0.029
  81. DOACs for AF After?TAVR: Are DOACs Really on First Base? JACC Cardiovasc Interv. 2021 02 22; 14(4):481.
    View in: PubMed
    Score: 0.029
  82. Hospital Volume and Outcomes of Coronary Atherectomy. Am J Cardiol. 2021 05 01; 146:140-141.
    View in: PubMed
    Score: 0.029
  83. Outcomes of Transcarotid Versus Trans-Subclavian Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis. Cardiovasc Revasc Med. 2021 12; 33:20-25.
    View in: PubMed
    Score: 0.029
  84. Outcomes of transcatheter versus surgical aortic valve replacement among solid organ transplant recipients. Catheter Cardiovasc Interv. 2021 03; 97(4):691-698.
    View in: PubMed
    Score: 0.029
  85. Impact of adherence to the hybrid algorithm for initial crossing strategy selection in chronic total occlusion percutaneous coronary intervention. Rev Esp Cardiol (Engl Ed). 2021 Dec; 74(12):1023-1031.
    View in: PubMed
    Score: 0.029
  86. Transulnar Versus Transradial Access for Coronary Angiography and Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled Trials. Cardiovasc Revasc Med. 2021 05; 26:39-45.
    View in: PubMed
    Score: 0.029
  87. Temporal trends and outcomes of critical limb ischemia among patients with chronic kidney disease. Vasc Med. 2021 04; 26(2):155-163.
    View in: PubMed
    Score: 0.029
  88. Outcomes with catheter-directed thrombolysis compared with anticoagulation alone in patients with acute deep venous thrombosis. Catheter Cardiovasc Interv. 2021 01 01; 97(1):E61-E70.
    View in: PubMed
    Score: 0.028
  89. Impact of Intravascular Ultrasound Utilization for Stent Optimization on 1-Year Outcomes After Chronic Total Occlusion Percutaneous Coronary Intervention. J Invasive Cardiol. 2020 Oct 01; 32(10):392-399.
    View in: PubMed
    Score: 0.028
  90. Impact of Successful Chronic Total Occlusion Percutaneous Coronary Interventions on Subsequent Clinical Outcomes. J Invasive Cardiol. 2020 Nov; 32(11):433-439.
    View in: PubMed
    Score: 0.028
  91. Use of Direct Oral Anticoagulants in the Treatment of Left Ventricular Thrombi: A Systematic Review. Am J Med. 2020 11; 133(11):1266-1273.e6.
    View in: PubMed
    Score: 0.028
  92. Clinical Characteristics and Outcomes?of?STEMI Patients With Cardiogenic Shock and Cardiac Arrest. JACC Cardiovasc Interv. 2020 05 25; 13(10):1211-1219.
    View in: PubMed
    Score: 0.028
  93. Racial Disparities in the Utilization and Outcomes of Transcatheter Mitral Valve Repair: Insights From a National Database. Cardiovasc Revasc Med. 2020 11; 21(11):1425-1430.
    View in: PubMed
    Score: 0.028
  94. Distal Versus Conventional Transradial Artery Access for Coronary Angiography and Intervention: A Meta-Analysis. Cardiovasc Revasc Med. 2020 10; 21(10):1209-1213.
    View in: PubMed
    Score: 0.028
  95. Retrograde Chronic Total Occlusion Percutaneous Coronary Intervention via?Saphenous Vein Graft. JACC Cardiovasc Interv. 2020 02 24; 13(4):517-526.
    View in: PubMed
    Score: 0.027
  96. Sex Differences in In-Hospital Outcomes of Transcatheter Mitral Valve Repair (from a National Database). Am J Cardiol. 2020 05 01; 125(9):1391-1397.
    View in: PubMed
    Score: 0.027
  97. Temporal Trends and Outcomes of Transcatheter Mitral Valve Repair Among Nonagenarians. JACC Cardiovasc Interv. 2020 06 08; 13(11):1385-1387.
    View in: PubMed
    Score: 0.027
  98. Outcomes of subintimal plaque modification in chronic total occlusion percutaneous coronary intervention. Catheter Cardiovasc Interv. 2020 11; 96(5):1029-1035.
    View in: PubMed
    Score: 0.027
  99. Meta-Analysis Comparing Torsemide Versus Furosemide in Patients With Heart Failure. Am J Cardiol. 2020 01 01; 125(1):92-99.
    View in: PubMed
    Score: 0.027
  100. In-Hospital Outcomes with Transfemoral Versus Transapical Access for Transcatheter Aortic Valve Replacement in Patients with Peripheral Arterial Disease. Cardiovasc Revasc Med. 2020 05; 21(5):604-609.
    View in: PubMed
    Score: 0.027
  101. Impact of diastolic dysfunction on long-term mortality and quality of life after transcatheter aortic valve replacement. Catheter Cardiovasc Interv. 2020 04 01; 95(5):1034-1041.
    View in: PubMed
    Score: 0.026
  102. Low-Risk Transcatheter Versus Surgical Aortic Valve Replacement - An Updated Meta-Analysis of Randomized Controlled Trials. Cardiovasc Revasc Med. 2020 04; 21(4):441-452.
    View in: PubMed
    Score: 0.026
  103. Recent advances in microcatheter technology for the treatment of chronic total occlusions. Expert Rev Med Devices. 2019 Apr; 16(4):267-273.
    View in: PubMed
    Score: 0.026
  104. In-hospital outcomes of transcatheter versus surgical aortic valve replacement for nonagenarians. Catheter Cardiovasc Interv. 2019 04 01; 93(5):989-995.
    View in: PubMed
    Score: 0.025
  105. Outcomes of Surgical Ablation in Patients With Atrial Fibrillation Undergoing Cardiac Surgeries. Ann Thorac Surg. 2019 May; 107(5):1395-1400.
    View in: PubMed
    Score: 0.025
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES